Detalhe da pesquisa
1.
Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells.
Immunity
; 51(3): 573-589.e8, 2019 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31474513
2.
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy.
Blood
; 143(16): 1565-1575, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38252906
3.
Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.
Immunity
; 44(4): 924-38, 2016 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27096321
4.
DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance.
Immunity
; 42(6): 1143-58, 2015 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26070485
5.
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th-December 1st, 2022).
J Transl Med
; 21(1): 488, 2023 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37475035
6.
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st-2nd, 2021.
J Transl Med
; 20(1): 257, 2022 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35672823
7.
The "Great Debate" at Immunotherapy Bridge 2020, December 3rd, 2020.
J Transl Med
; 19(1): 144, 2021 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33827609
8.
SOX11 augments BCR signaling to drive MCL-like tumor development.
Blood
; 131(20): 2247-2255, 2018 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29615403
9.
ENGINE: a Phase III randomized placebo controlled study of enzastaurin/R-CHOP as frontline therapy in high-risk diffuse large B-cell lymphoma patients with the genomic biomarker DGM1.
Future Oncol
; 16(15): 991-999, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32250167
10.
Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
Blood
; 129(6): 759-770, 2017 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28011673
11.
A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells.
Blood
; 127(26): 3398-409, 2016 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27114459
12.
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells.
Blood
; 125(7): 1061-72, 2015 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25488972
13.
ß-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors.
PLoS Genet
; 9(8): e1003603, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23966864
14.
High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells.
Blood
; 121(8): 1367-76, 2013 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23297127
15.
Improving outcomes with checkpoint blockade in non-Hodgkin lymphoma.
Clin Adv Hematol Oncol
; 18(5): 273-275, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32628655
16.
A vaccine directed to B cells and produced by cell-free protein synthesis generates potent antilymphoma immunity.
Proc Natl Acad Sci U S A
; 109(36): 14526-31, 2012 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-22875703
17.
Immunosuppressive effects of erythropoietin on human alloreactive T cells.
J Am Soc Nephrol
; 25(9): 2003-15, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24676641
18.
In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study.
Blood
; 119(2): 355-63, 2012 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22045986
19.
T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses.
Cancer Immunol Res
; 12(3): 296-307, 2024 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240659
20.
Phase I Study of GS-3583, a FLT3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors.
Clin Cancer Res
; 2024 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38295150